- Drug Pipelines
- June 2020
- 1184 Pages
From €2174EUR$2,500USD£1,935GBP
- Report
- May 2020
- 98 Pages
From €1566EUR$1,800USD£1,393GBP
- Report
- May 2020
- 48 Pages
From €1566EUR$1,800USD£1,393GBP
- Report
- May 2020
- 199 Pages
From €3479EUR$4,000USD£3,095GBP
- Drug Pipelines
- January 2017
- 60 Pages
From €1087EUR$1,250USD£967GBP
- Newsletter
- January 2020
From €1010EUR$1,244USD£930GBP
- Report
- September 2020
- 2006 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2087 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2160 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2024 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2111 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2079 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2054 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2073 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2173 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2091 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2087 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2095 Pages
€3349EUR$3,850USD£2,979GBP
- Report
- September 2020
- 2079 Pages
€3349EUR$3,850USD£2,979GBP
- Drug Pipelines
- June 2020
- 3889 Pages
From €2174EUR$2,500USD£1,935GBP

Colon (or colorectal/bowel cancer) is diagnosed in over 1 million people annually, and accounts for over 0.5 million deaths each year. According to a recent article in the renowned Lancet medical journal, in Europe the 5-year survival for colorectal cancer is less than 60% so there is certainly considerable market potential for effective and accessible new pharmaceutical drugs. Reports in the Colon Cancer Section will help industry operators, and those considering entering this market, to answer the key questions such as what are the latest clinical trials, what are the R&D trends, what is the potential for personalized medicine, where are the opportunities in major markets such as China and the US, etc. Show Less Read more